Bio-Techne (TECH) Income from Continuing Operations (2009 - 2026)

Bio-Techne (TECH) recorded quarterly Income from Continuing Operations of 51047000.0 in Q1 2026, up 34.3% quarter-over-quarter from 38009000.0 in Q4 2025, and up 125.99% on a YoY basis from 22588000.0 in Q1 2025.

Bio-Techne (TECH) Income from Continuing Operations (2009 - 2026) Analysis & Trends

Bio-Techne's Income from Continuing Operations history runs 18 years deep, the most recent figure standing at 51047000.0 for Q1 2026.

  • In Q1 2026, Income from Continuing Operations rose 125.99% year-over-year to 51047000.0; the TTM figure through Mar 2026 stood at 22749000.0 (down 71.78% YoY), while the FY2025 annual figure was 13414000.0, down 111.46% from the prior year.
  • Income from Continuing Operations was 51047000.0 for Q1 2026 at Bio-Techne, up from 38009000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 89734000.0 in Q3 2022 to a low of 104492000.0 in Q2 2025.
  • Historically, Income from Continuing Operations has averaged 35799352.94 across 5 years, with a median of 45685000.0 in 2023.
  • The sharpest annual moves came in 2022 and 2025: Income from Continuing Operations soared 193.98% in 2022, then tumbled 899.35% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 50005000.0 in 2022, then sank by 45.08% to 27465000.0 in 2023, then advanced by 27.03% to 34890000.0 in 2024, then advanced by 8.94% to 38009000.0 in 2025, then jumped by 34.3% to 51047000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 51047000.0 (Q1 2026), 38009000.0 (Q4 2025), and 38185000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 30.80 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.40 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -14.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.03 Bn
9 Abivax 91.96 Bn 91.96 Bn - -56.48 Mn
10 Bio-Techne 9.04 Bn 8.83 Bn 208.29 Mn 51.05 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 51.05 Mn
Dec 31, 2025 38.01 Mn
Sep 30, 2025 38.19 Mn
Jun 30, 2025 -104.49 Mn
Mar 31, 2025 22.59 Mn
Dec 31, 2024 34.89 Mn
Sep 30, 2024 33.60 Mn
Jun 30, 2024 -10.46 Mn
Mar 31, 2024 49.06 Mn
Dec 31, 2023 27.47 Mn
Sep 30, 2023 50.99 Mn
Jun 30, 2023 45.69 Mn
Mar 31, 2023 70.22 Mn
Dec 31, 2022 50.01 Mn
Sep 30, 2022 89.73 Mn
Jun 30, 2022 61.92 Mn
Mar 31, 2022 60.14 Mn
Dec 31, 2021 72.06 Mn
Sep 30, 2021 68.98 Mn
Jun 30, 2021 -65.88 Mn